SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-18-078418
Filing Date
2018-03-12
Accepted
2018-03-12 08:56:35
Documents
73
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d501837d10k.htm 10-K 1260338
2 EX-23.1 d501837dex231.htm EX-23.1 2066
3 EX-31.1 d501837dex311.htm EX-31.1 7184
4 EX-31.2 d501837dex312.htm EX-31.2 7190
5 EX-32.1 d501837dex321.htm EX-32.1 5392
12 GRAPHIC g501837g43e33.jpg GRAPHIC 85134
  Complete submission text file 0001193125-18-078418.txt   6145386

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT zsan-20171231.xml EX-101.INS 1067692
7 XBRL TAXONOMY EXTENSION SCHEMA zsan-20171231.xsd EX-101.SCH 62980
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zsan-20171231_cal.xml EX-101.CAL 73579
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zsan-20171231_def.xml EX-101.DEF 271626
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE zsan-20171231_lab.xml EX-101.LAB 563058
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zsan-20171231_pre.xml EX-101.PRE 397958
Mailing Address 34790 ARDENTECH COURT FREMONT CA 94555
Business Address 34790 ARDENTECH COURT FREMONT CA 94555 510-745-1200
Zosano Pharma Corp (Filer) CIK: 0001587221 (see all company filings)

IRS No.: 454488360 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36570 | Film No.: 18682231
SIC: 2834 Pharmaceutical Preparations